1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it
Banner Top
  1. Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results:
  2. Treating Yourself Relaunches Medical Cannabis Website
  3. Sunniva Announces Completion of $15 Million Convertible Debenture Financing
  4. Supreme Cannabis Announces Q2 2019 Financial Results
  5. ‘This is the new Vitamin C’: Biome Grow to sign major CBD source deal
  6. Could Cannabis Cosmeceuticals be the Next Billion Dollar Idea?
  7. Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres
  8. Aurora Releases Q2 Financial Results
  9. O’Cannabiz Toronto Expo, Conference & Industry Awards April 25-27 2019
  10. Biome Grow announces first shipment of finished product to Newfoundland and Labrador
  11. Supreme Cannabis Expands Domestic Distribution to Eight Provinces
  12. 48North Closes its $10 million Private Placement
  13. Aphria’s Board of Directors Rejects Green Growth Brand’s Hostile Takeover Bid
  14. Planet 13 Announces Customer Traffic for January 2019
  15. iAnthus and MPX Bioceutical Announce Closing of $1.6 Billion Business Combination
  16. Namaste Board Launches Strategic Review Process; Announces Termination of CEO Sean Dollinger and Commences Legal Action
  17. World Health Organization Recommends Rescheduling Marijuana Under International Treaties
  18. What Drove Altria’s Revenue in the Fourth Quarter?
  19. Surprise! Tilray’s CEO Just Dumped $11 Million in Stock
  20. Origin House Signs Exclusive Distribution Agreement and Provides Strategic Financing to Utopia Cannabis
  21. Slang, a Canopy Growth-backed Cannabis Company on CSE, off to Half-Billion Dollar Valuation
  22. PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
  23. Origin House Signs Exclusive Agreement with Viola Brands for California
  24. TGOD Completes Knud Jepsen Agreement
  25. Green Growth Brands Files Offer to Purchase and Circular for Aphria Inc.; Aphria Urges Shareholders to “Take No Action”
  26. MPX Receives Final Court Approval for Arrangement with iAnthus
  27. Invictus MD Announces Submission Of Its Application To List On NASDAQ And Share Consolidation
  28. HEXO to Begin Trading on the NYSE American, Announces Results of AGM
  29. Nova Scotia’s Highland Grow Secures Second Purchase Order with the NSLC
  30. MPX Securityholders Approve Business Combination with iAnthus
  31. Invictus and GTEC Holdings Announce Formal Termination Of Merger Plans
  32. Biome Opens the Door to U.S. Investors
  33. Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
  34. Aurora to Acquire Whistler
  35. Aphria Releases Q2 Results as Founders Step Down
  36. Curaleaf Set To Expand Operations In Maryland With New Financing And Purchase Option Agreements
  37. PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
  38. Emerald Health Closes Emerald Health Naturals Joint Venture
  39. Biome Grow subsidiary, Highland Grow secures purchase order with NSLC and sends first shipment of finished product
  40. SUPREME CANNABIS RECEIVES CONDITIONAL APPROVAL TO LIST ON THE TORONTO STOCK EXCHANGE
  41. KUSHCO HOLDINGS REPORTS FIRST FISCAL QUARTER 2019 RESULTS
  42. Aurora Cannabis Provides Guidance for the Second Quarter of Fiscal 2019, Anticipating Net Revenues of $50M to $55M
  43. Curaleaf Launches Its 20th Medical Marijuana Dispensary in Florida
  44. iAnthus Opens Flagship Citiva Dispensary in Brooklyn
  45. TGOD Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada
  46. The Fastest-Growing Marijuana Stocks in 2019
  47. Biome Announces OTCQB Listing
  48. Green Growth Brands Launches Hostile Takeover Bid for Aphria Inc.
  49. Cannabis Stocks Mixed on Monday
  50. Health Canada Announces Proposed Regulations for Cannabis Edibles, Extracts, and Topicals
  51. Northland Capital Initiates Coverage on Planet 13 Holdings
  52. Details on Ontario’s New Private Cannabis Retail Lottery
  53. GrowHealthy Opens First Flagship Dispensary in Florida, With Plans for Two More by End of 2018
  54. Biome Grow Receives Amended Health Canada Sales License for its Nova Scotia-based Highland Grow.
  55. Canada’s Largest Province To Approve Only 25 Store Licences Due to Supply Shortage
  56. The Next Cannabis Wave? A $3.7 Trillion Wellness Market
  57. Canopy Growth announces multi-year extraction agreement with Valens GroWorks
  58. Here’s Why Marijuana Stocks Deserve Coal in Their Stockings This Year
  59. Biome Receives DTC Eligibility in United States, OTC symbol “ORTFF”
  60. U.S. House of Representatives Passes the Farm Bill
  61. Mississauga and Markham Opt-Out of Cannabis Retail Stores
  62. Interview with Diane Scott, Chairman and Chief Executive Officer, Jamaican Medical Cannabis Corporation (JMCC)
  63. Canada’s Aurora Cannabis buys Mexico’s Farmacias Magistrales
  64. Altria Moves into the Herd
  65. Cronos group inc. Announces c$2.4 billion strategic investment from altria group, inc
  66. Canopy Acquires Storz & Bickel
  67. CANNABIS MEETS HEALTHCARE
  68. Aphria Shares Down this Morning
  69. 48North Has Two Major Announcements
  70. Cannabis stock report: Congress agrees on new farm bill legislation, CBD industry readies to explode
  71. Cannabis Daily’s Top 35 Stocks Now Updated
  72. iAnthus Announces Third Quarter 2018 Financial Results
  73. Green Thumb Industries (GTI) Announces Year-over-Year Revenue Growth of 344% and Sequential Revenue Growth of 26% for Third Quarter 2018
  74. 48North Cannabis Corp. Announces Revenue Growth for Fiscal Q1 2019
  75. KUSHCO HOLDINGS REPORTS FISCAL YEAR 2018 RESULTS
  76. Canada’s Grand Cannabis Experiment Has Set Scientists Free
  77. What Did Canadian Cannabis Legalization Do to the Stock Markets?
  78. Cannabis 3.0?
  79. Cannabis firms spent millions marketing their pot last quarter – did it work?
  80. Biome Grow, Now Publicly Traded but Falling Under the Radar
  81. John Boehner-Backed Pot Firm Sees This Boosting U.S. Weed Listings
  82. MJBizCon Las Vegas Redefines Scale in Cannabis Trade Shows
  83. Ontario Establishes Strict Regulations for the Licensing and Operation of Private Cannabis Stores
  84. Canopy Growth Losses Widen Sharply, But Cannabis Sales Prices Spike
  85. Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
  86. Université de Moncton partners with the Government of Canada, Genome Atlantic, Genome Canada, New Brunswick Innovation Foundation, and Organigram to advance cannabis research and increase productivity
  87. Aurora Cannabis Earnings Kick Off Big Week For Marijuana Stocks After Canada Recreational Legalization
  88. Legalization… What’s Next?  Clear the Smoke at O’Cannabiz Conference and Expo Vancouver
  89. Biome Grow announces supply and production agreement with Province of Newfoundland and Labrador, including distribution and retail services
  90. Trump ousts Jeff Sessions as attorney general
  91. Marijuana Stocks Moved Higher On Election Results
  92. Is the cannabis industry armed against privacy breaches?
  93. Is Emblem Corp (CVE:EMC) A Financially Sound Company?
  94. Midterm elections and marijuana: Part III, recreational use initiatives
  95. Biome Grow’s Announcement in Newfoundland Demonstrates its Large-Scale Commitment to Atlantic Canada
  96. Cannabis Stocks Reversed Some Losses Last Week
  97. O’Cannabiz Vancouver Brings Together Montel Williams, Leading Cannabis Advocates and Innovators
  98. Forget October: Here’s the Right Marijuana Move for Investors Now
  99. Better Marijuana Stock: Canopy Growth vs. Canopy Rivers
  100. Biome Grow (BIO.C) signs huge supply deal with Newfoundland
  101. Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC
  102. Spectrum Cannabis welcomes JWC dried cannabis products to its online platform
  103. 3 Marijuana Stocks Taking Advantage of Global CBD Growth
  104. Falling Pot Stocks Hammer Canada’s Struggling Venture Exchange
  105. Cannabis Sector Didn’t Fare So Well Last Week
  106. How Pot Chain MedMen Sounds Like A Typical Retailer With This New Plan
  107. Biome Grow Introduces Ontario-based brand, Great Lakes Cannabis
  108. Kushco Holdings Joins Sustainable Packaging Coalition
  109. Sales of Marijuana in Colorado Continue to Climb
  110. Monday Morning Coming Down
  111. Biome Grow Introduces PEI Brand, Red Sands Craft Cannabis Co.
  112. Mary’s Wellness Pitching CBC Dragon’s Den Tonight
  113. Biome Grow Announces Listing on the Frankfurt Stock Exchange under symbol 60TA
  114. Home-Use THC and CBD Test Kits Now Available in Canada
  115. Looking for Work in Cannabis? Careers Cannabis’ New Platform Launches Today
  116. Canada becomes first industrialised nation to legalise cannabis
  117. Biome Grow is Investing in Atlantic Canadian Cannabis Sector
  118. The Canadian Province With The Most Pot Smokers Was Just Revealed And It’s Not At All Who You Thought It Would Be
  119. The Cannabis Society and Fireside Cannabis presents Canada’s Legalization party.
  120. Cannabis companies ramp up marketing as Health Canada warns them not to advertise pot
  121. CBP Statement on Canada’s Legalization of Marijuana and Crossing the Border
  122. Flower One Commences Trading on the CSE
  123. Canopy Growth Completes First Legal Medical Cannabis Export from Canada to the United States
  124. Aurora Cannabis Announces Application to List on the NYSE
  125. BIOME GROW Begins Trading on CSE Under Symbol (BIO)
  126. Remember When?
  127. NICHE Canada’s Cannabis & Our Community Series Continues in Calgary October 23rd
  128. Biome Grow Closes Fundamental Change Transaction
  129. 10 Of The Richest Cannabis Millionaires — And How They Made Their Money
  130. Cannabis Sector Down After Pepsi’s Statement
  131. Rumors of a Crop Failure at Canopy’s Aldergrove, BC Facility
  132. Dixie Brands, Inc. Going Public, Expanding Operations
  133. As Major Beverage Companies Eye Cannabis Industry, Consumer Trends Expected to Follow Suit
  134. Cannabis company withdraws ‘Chronic by Dre’ trademark it filed without Dr. Dre’s permission
  135. Aphria unveils comprehensive portfolio of adult-use brands
  136. DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?
  137. SUPREME CANNABIS SIGNS CANNABIS SUPPLY AGREEMENT WITH TILRAY®
  138. New Ontario Cannabis Regulations Could Be a Breath of Fresh Air
  139. Our first exposure to The Cannabis Society both eye-opening and insightful
  140. Cannabis Sector Stayed in the Green Last Week
  141. Aurora Cannabis releases earnings, confirms U.S. listing plans
  142. Who is Biome Grow and What a Good Business Plan Means to Cannabis Investors
  143. Keep your arms and legs in the car at all times…
  144. Aphria Signs Supply Agreements with all Provinces and Yukon
  145. The Stock That Can’t Stay Out of the News
  146. Tilray Led Cannabis Stocks Higher as Sector Continues to Rally
  147. Tilray Drops Namaste Contract
  148. Coca-Cola and Aurora. Is it the Real Thing?
  149. CEO Hotline – Greg Pantelic, Think AHLOT Corporation
  150. Global Cannabis Partnership Welcomes New Members
  151. iAnthus Capital Holdings, Inc. Announces $30 Million Bought Deal Financing
  152. Organigram signs supply agreement with Newfoundland and Labrador Liquor Corporation
  153. Aphria Announces Director Resignation and Appointment
  154. Emblem launches Atmosphere, Its First Oral Dose-Metered Spray
  155. Organigram invests in Hyasynth Biologicals Inc.
  156. Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
  157. Insights on the Cannabis Industry
  158. Rolling Stone: New Report Predicts CBD Market Will Hit $22 Billion by 2022
  159. NICHE Canada and Aurora Cannabis Launch Guide for Municipal Candidates on Cannabis Legalization and Implementation
  160. Aurora Cannabis-ICC Labs Deal Fuels Marijuana Stock Momentum
  161. EVENT: Cannabis & Our Community – Toronto, Sept 25, 2018
  162. Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
  163. Cannabis Daily and Puffin Style Media Sponsorships
  164. Marijuana Stocks: Short-Seller Citron Research Puts Tilray Stock In Cross Hairs
  165. Demystifying the Science and Economics of Smart Temperature and Humidity Control
  166. Vertical Integration
  167. Take a Deep Dive into Highland Grow’s Antigonish, Nova Scotia Operation
  168. Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
  169. iAnthus Announces Second Quarter 2018 Financial Results
  170. Starseed Holdings Inc. Launches Saturday, its New Adult-Use Cannabis Brand
  171. Supreme Cannabis Secures Supply Agreements with Nova Scotia and Prince Edward Island
  172. Nova Scotia cannabis distributor hopes local products will be on NSLC shelves by Oct. 17
  173. Cannabis ETF Surges as Alcohol Industry Looks to Marijuana
  174. Aphria selected by the Nova Scotia Liquor Corporation to supply Nova Scotia’s adult-use cannabis market
  175. AB InBev, Pepsi, Coca-Cola All Likely Eyeing Cannabis: Former Alcohol Industry Exec
  176. Biome Grow announces conditional approval for listing on the Canadian Securities Exchange
  177. The Best Under-the-Radar Marijuana Stock I’ve Seen So Far
  178. Biome Grow – Investor Awareness Event
  179. Pot stocks rampage amid expectations of more big deals with traditional companies
  180. Cannabis Daily Launches Cannabis Lifestyle Website
  181. Organigram signs supply agreement with Nova Scotia Liquor Corporation
  182. Cannabis Drinks Expo Announces Canopy Growth Corp. CEO Bruce Linton Will Headline Event
  183. Aurora Cannabis Obtains Health Canada Approval for Softgel Capsule Production: Launches CanniMed Capsules 3:3
  184. The MJBizCon Int’l Conference Brought American Canna-Business to Toronto
  185. Aphria Signs Agreement with OCS
  186. The OCS Announces its Suppliers
  187. Emerald Health Therapeutics Announces Appointment of Pure Sunfarms President and CEO
  188. Weed’s Big Day
  189. The Green Organic Dutchman Signs Agreement to Acquire Leading European CBD Company HemPoland
  190. Let's Face It: Marijuana Stocks Won't Live Up to the Hype
  191. Aurora Cannabis and MedReleaf Confirm Supply Agreements with Ontario Cannabis Stores
  192. Organigram becomes an official cannabis supplier to the Province of Ontario, Canada’s largest adult recreational market
  193. Canopy Growth secures over 100 product listings in Ontario
  194. The Google of Cannabis? Hmm…
  195. Dry Counties
  196. TGOD Reports $8.5M Loss for Quarter ended June 30, 2018
  197. Kush Bottles Launches Their Canadian Division
  198. Cannabis company Canopy Growth’s stock soars 30% as Corona brewer increases stake
  199. Aurora Cannabis and McGill University Partner in International Research Project
  200. Constellation Brands makes additional $4 billion investment in cannabis company Canopy Growth
  201. Are Cannabis Investors Forgetting the Lessons of the Dot Com Era? First-to-Market May Not Win.
  202. THC BioMed Develops Cannabis Beverage
  203. What’s the Analyst Consensus on Aphria?
  204. Canopy Growth Completes Canopy Health Innovations Acquisition
  205. Has Canadian Marijuana Officially Bypassed Mainstream and Gone Corporate?
  206. How Trump’s trade battles are affecting the marijuana industry
  207. Aphria Records Higher Annual Sales and Higher Quarterly Loss Due to Pending Canadian Legalization
  208. 48North Invites Women To Speak-Up About Their Cannabis Use
  209. ABcann to Acquire Leading B.C. Producer Canna Farms
  210. Ontario said to announce big change in plans for marijuana retailing under Doug Ford
  211. The Greenfield 4:20 Fire and its Implications
  212. Aurora Cannabis and MedReleaf Close the World’s Largest Cannabis Industry Transaction
  213. CEO Hotline: Khurram Malik, Interim CEO, Biome Grow
  214. Marijuana operator Acreage Holdings announces landmark $119 million funding
  215. Cannabis Sector Continued to Slide Last Week
  216. Aphria provides update on investments
  217. Aurora, MedReleaf shareholders clear path toward Canada’s largest cannabis deal
  218. Step into the first virtual reality cannabis dispensary
  219. One Stop Shops? Not with the Kids. NSLC Shows Their Store.
  220. Khiron Appoints Former Mexican President Vicente Fox to Board of Directors
  221. Selling Cannabis in Jamaica – Wait…What?
  222. Aurora Cannabis Selects Shopify to Power Global ECommerce Platform
  223. British Columbia’s Liquor Board Announces the Province’s 31 Bud Suppliers
  224. Kush Bottles Reports Third Fiscal Quarter 2018 Results, Name Change and Restructuring
  225. Canopy Growth Moves to Acquire Hiku Brands Company
  226. Biome Grow Announces Appointment of Steven Poirier to its Board of Directors
  227. Alberta Announces the ‘Lucky 13’
  228. Canada to legalise smoking pot: Can these stocks smoke the ASX?
  229. Legal Marijuana Is Coming to Canada. Investors Catch the Buzz.
  230. Analyst Recommendations for Two Leading Cannabis Stocks
  231. Cannabis Promotion in Canada? See Tobacco. Tobacco Promotion in Canada? See Kryptonite.
  232. CEO of the Green Organic Dutchmen Resigns, New CEO and CFO Appointed
  233. 3 Best Marijuana Stocks of 2018 So Far — Are They Buys Now?
  234. CEO Hotline: The Cannabis Executive Search Agency
  235. Canadian Company Makes Historic Investment in Jamaican Medical Cannabis Research
  236. Orca Touchscreen Technologies Shareholders Approve Amalgamation with Biome Grow
  237. Why Canopy Growth Corp’s Shares Plunged 12% Today
  238. TGOD Holdings Accelerates European Expansion with Denmark Joint Venture
  239. Cann Group secures Australia’s largest medicinal cannabis operation
  240. Top Four Developments We’re Watching in Cannabis Sector: Part 2
  241. Aurora Cannabis signs loan deal for up to $250 million with Bank of Montreal
  242. Cannabis Drinks Gaining Visibility
  243. B.C. Announces Central Cannabis Warehouse and Online Platform
  244. Six Key Differentiation Points for the Cannabis Market in Canada
  245. Canada Legalizes Recreational Marijuana: What’s Next for Pot Stocks?
  246. Cultivator Catalyst Corp to go public with tech firm Orca
  247. Move Over Tech: Marijuana Stocks Are the New Star
  248. The Post-Prohibition Era in Canada Begins
  249. Canadian Senate Approves Bill C-45
  250. High Times refreshes IPO plans as cannabis companies build buzz on Wall Street
  251. Weed VR – Future Tech Today
  252. 48North Launches Scholarship Program for Entrepreneurial Women in Cannabis
  253. CannTrust strives to be a leader in the cannabis industry with a 450,000 square foot facility in Niagara, ON.
  254. Biome Grow announces agreement to acquire Weed Virtual Retail
  255. Here’s how Canada compares with the rest of the world when it comes to cannabis legalization
  256. CannabisMD and CBD’s Medicinal Application
  257. Khiron Life Sciences First To Enter 5-Million Strong Colombia Medical Cannabis Market
  258. House of Commons to Reinstate Rights of Canadians to Grow Cannabis
  259. Welcome to Cannada -Part 3. The New Cannabis Economy
  260. Cannabis Delivery Services: Curation and Connection
  261. Avoid These Obvious Mistakes When Investing In Cannabis Stocks
  262. 5 Must-See Quotes From Aurora Cannabis on Worldwide Weed Opportunities
  263. Trump Signals Support for Legislation Easing US Ban on Pot
  264. Large Indoor Hydroponic Facility – New On the CSE
  265. A Hitchhiker’s Guide to Recreational Cannabis
  266. CEO of Lift & Co’s Consumer-Centric Vision
  267. On the Morning of Canadian Senate Vote, Weed Stocks Down
  268. 2nd Annual O’Cannabiz Conference Toronto
  269. Now Growing More Than Tomatoes & Cucumbers
  270. Welcome to Cannada -Part 2. The Cannabis Stock Exchange
  271. Newfoundland and Labrador’s Back Home Medical Cannabis Corp. becoming a reality thanks to investment from Biome Grow
  272. Welcome to Cannada. Part I – The Canadian Cannabis Future
  273. Deloitte Reports that Canadians Will Spend $7.2B Next Year on Cannabis
  274. As C-45 Passage Approaches, Greg Engel, CEO of OrganiGram, Shares His Thoughts
  275. Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation
  276. On the Verge of Becoming Canada’s Largest Cannabis Producer
  277. Khiron Life Sciences Corp. New on the TSX – Medical Cannabis for Latin America
  278. C-45 Progresses in the Canadian Senate as the Industry Ramps Up
  279. 8 Canadian Marijuana Growers Expected to Top 100,000 Kilograms of Annual Production
  280. Canopy Growth Announces Five Retail Locations in Saskatchewan
  281. MedMen CEO Sees Untapped Potential in Marijuana Market
  282. Canopy Growth Corporation announces entry into the African market with acquisition of Daddy Cann Lesotho
  283. Meet Nova Scotia’s 3 legal cannabis growers
  284. JMCC Aims to Supply Canadian LPs with Jamaican Premium Cannabis
  285. MedMen Begins Trading Under Ticker Symbol “MMEN” on the Canadian Securities Exchange
  286. MedReleaf and BioPharma Services Inc. Announce Strategic Alliance
  287. Cannabis Sector Back in the Red for Week Ended May 25
  288. What Investors Are Paying for Cannabis Sector’s Forward Sales
  289. As Ontario Votes, We Ask the Candidates Where They Stand on Cannabis.
  290. Biome announces acquisition of land in Nova Scotia to dramatically increase the production footprint of its ACMPR Licensed Producer
  291. With Legalization Colorado Invited Growers into the State. Here’s What Happened
  292. Looking for Work Women? Perhaps the Grass is Greener in the Cannabis Industry
  293. Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.
  294. Highland Grow Inc. Boosts its Quality Assurance and Regulatory Compliance Ranks
  295. Lift & Co. Cannabis Expo Illustrates the Changing Nature of the Business
  296. Diagnostics, Testing and Support – The Coming Wave
  297. From the Big Smoke to the Big Board
  298. Biome Grow expects completion of first province-based cannabis production facility this year
  299. Oils – Are They Secret Sauce to Profitability?
  300. Organigram Receives Permit to Export Medical Cannabis to Australia
  301. Morning Briefing -Top 9 Stocks To Follow
  302. Biome Grow Expects to Complete First Newfoundland and Labrador-based Cannabis Production Facility in 2018
  303. Biome Grow Announces Name Change of its Nova Scotia-Based ACMPR Licensed Producer to Highland Grow Inc.
  304. Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
  305. Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
  306. Cannabis Stocks Heat Up on News of $3.2 Billion Aurora & MedReleaf Deal
  307. Aurora Cannabis to Acquire MedReleaf
  308. Opportunity Watchlist: Orca Touchscreen & Cultivator Catalyst Corp. Amalgamation to ‘Biome Grow Inc.’
  309. New on the TSX: InMed Pharmaceuticals
  310. Canadian Cannabis Stocks Continue to Dominate the Market
  311. Organigram Announces First International Expansion Investment
  312. Moody’s Expects Marijuana to See Limited Revenue
  313. Tweed Announces Location of Newfoundland Production Site and First Retail Locations
  314. How to Invest in Cannabis – In Its Many Forms
  315. Should You Invest In Cannabis Stocks?
  316. Top 4 Marijuana Stocks to Watch
  317. CEO Hotline Puts You In The Know
  318. 10 Canadian Marijuana Stocks for Your Portfolio
  319. Pot Stocks To Buy Now
  320. High Hampton Holdings Offers Investors Smart, Diversified Exposure to North America’s Fastest-Growing Marijuana Market
  321. MedMen in Binding ‘Letter of Intent’ To Merge Into Public Company in Canada
  322. American Cannabis Stocks
  323. Orca Touchscreen Enters Into Letter of Intent With Cultivator Catalyst Corp.
  324. Saw that it was covered
  325. Chooses to enjoy a pleasure
  326. These matters to this principle
  327. Heaven and earth seem
  328. Had grass morning
  329. Where they abused her
  330. Replenish itself
  331. I neglect my talents
  332. Grammar resulting language
  333. Where it came from it

TSX:ACB, TSX:LEAF

Transaction to Create Preeminent Global Cannabis Company

EDMONTON and MARKHAM, ON , May 14, 2018 /PRNewswire/ – Aurora Cannabis Inc. (“Aurora”) (TSX: ACB) and MedReleaf Corp. (“MedReleaf”) (TSX: LEAF) are pleased to announce that they have entered into a definitive arrangement agreement (the “Arrangement Agreement”) whereby Aurora intends to acquire all of the issued and outstanding common shares of MedReleaf in an all-share transaction valued at approximately C$3.2 billion on a fully diluted basis (the “Transaction”).

Proposed Transaction

Under the terms of the Arrangement Agreement, holders of MedReleaf common shares will receive 3.575 common shares of Aurora for each MedReleaf common share held (the “Exchange Ratio”). Upon completion of the Transaction, existing Aurora and MedReleaf shareholders would own approximately 61% and 39% of the pro forma company, respectively, on a fully diluted basis.

The Exchange Ratio implies a price of C$29.44 per MedReleaf common share and a premium of approximately 34%, based on the 20-day volume weighted average prices of Aurora and MedReleaf common shares on the Toronto Stock Exchange as of May 11, 2018 .

Highlights of the Transaction

The proposed Transaction brings together two of Canada ‘s premier cannabis companies with fully-aligned strategic visions and production philosophies, as well as complementary assets, distribution networks, products, and capabilities. The combined company will meet what Aurora and MedReleaf management teams consider to be the critical success factors in the industry, creating a powerful platform for accelerated growth on a global scale:

  • Industry leading scale : the Transaction brings together two leading operators with a total funded capacity of over 570,000 kg per year of high-quality cannabis, through nine facilities in Canada and two in Denmark .
  • Low production costs and industry leading yields: Aurora’s automated greenhouses are expected to deliver industry-leading efficiency and low production costs, delivering sustainably robust margins. MedReleaf ‘s high-yield cultivation is expected to further enhance productivity and reduce costs across the combined entity’s facilities.
  • Extensive distribution channels in Canada and internationally: the two companies have established distribution agreements with Alberta ‘s Alcanna (formerly Liquor Stores), Quebec ‘s SAQ, Pharmasave and Shoppers Drug Mart in Canada , among others. Additionally, the companies have a rapidly growing international footprint through a network of in-country sales and distribution capabilities and supply and licensing agreements on five continents, including countries such as Germany , Italy , Brazil and Australia . Both companies are actively engaged in initiatives to further expand their international activities.
  • Proven execution and agility across the value chain: creating a combined company, fully integrated across the entire value chain. The combined entity will be enabled to move with more agility and speed to capitalize on diversified opportunities in both the domestic and international markets, and create new, higher-margin opportunities across the value chain.
  • Enhanced diversification: a more broadly diversified portfolio of award-winning high-quality flower and derivative products will enable the companies to establish strong brands across the various market segments.
  • Brand leadership : three established medical brands, Aurora, CanniMed and MedReleaf , coupled with a portfolio of consumer and wellness brands – San Rafael ’71, Woodstock , and AltaVie – all backed by detailed consumer and marketplace insights and advanced analytical frameworks.
  • Innovation and R&D excellence: the expanded scientific team will focus on developing a robust pipeline of marketable IP, accessing higher-margin segments and new revenue streams. Aurora’s Medical Centre of Excellence, formed through the combination of the Aurora and CanniMed science and product development teams, together with MedReleaf ‘s ongoing studies with recognized research institutes, are expected to continue to evolve product innovation and create additional momentum for brand equity development on a global scale.
  • Enhanced capital markets profile: the combined entity’s expanded capital markets profile is expected to appeal to a broader shareholder audience, enhance trading liquidity and increase weighting in index tracking portfolios.

“This is a transformational transaction that brings together two pioneering cannabis companies, both committed to high technology, high quality and low cost production, to create a powerful platform for accelerated growth and success on a global scale,” said Terry Booth , CEO of Aurora. “Our complementary assets, strategic synergies, and strong market positioning will provide us with critical mass and an excellent product portfolio in preparation for the adult consumer use market in Canada . Equally, the combination strengthens our capacity to service the rapidly expanding global medical cannabis markets, and amplifies our early-mover advantage. We are very excited about the combination of our respective science and R&D teams, which will position us exceptionally well for the development of high value-added products, addressing as yet unmet needs in the medical markets, and driving continued innovation for the adult consumer use market.”

Neil Closner , CEO of MedReleaf , added, ” MedReleaf was founded on the belief that by striving to be the Medical Grade Standard and bringing the highest level of quality and rigor to the cannabis industry, we would produce safe, consistent, and effective products that help improve the quality of life of our patients and, in time, provide an unrivaled experience for the adult use consumer. This, in turn, would drive growth and opportunity for our business. By combining with Aurora, an integrated producer with an exceptionally strong track record for execution, and deep domestic and international distribution capabilities, we will be ideally positioned to set the global standard for our industry at a pace that will be difficult to match.”

Board of Directors’ Recommendations

The Arrangement Agreement has been unanimously approved by the boards of directors of Aurora and MedReleaf , and each board recommends that their respective shareholders vote in favour of the Transaction.

The board of directors of MedReleaf and the special committee of the MedReleaf board of directors have obtained a fairness opinion from each of Canaccord Genuity Corp. and GMP Securities L.P. that, as of the date of the opinions, and subject to the assumptions, limitations, and qualifications on which such opinions are based, the consideration to be received by MedReleaf ‘s shareholders pursuant to the Arrangement Agreement is fair, from a financial point of view, to the MedReleaf shareholders. The board of directors of Aurora has obtained an opinion from BMO Capital Markets that, as of the date of the opinion, and subject to the assumptions, limitations, and qualifications on which such opinion is based, the Exchange Ratio provided for in the Arrangement Agreement is fair from a financial point of view to Aurora.

Transaction Summary

The Transaction will be effected by way of a plan of arrangement completed under the Business Corporations Act ( Ontario ). The Transaction will require approval by at least 66 2/3% of the votes cast by the shareholders of MedReleaf present at a special meeting of MedReleaf shareholders. The issuance of Aurora common shares in connection with the Transaction will require the approval of a simple majority of the shareholders of Aurora present at a special meeting. Directors and officers of Aurora and MedReleaf have entered into support agreements pursuant to which they have agreed to vote their shares in favour of the Transaction. In addition, holders of approximately 56% of MedReleaf ‘s issued and outstanding common shares have entered into irrevocable hard lock-ups to vote their shares in favour of the Transaction.

Upon completion of the Transaction, the board of directors of Aurora will be increased to 8 members, with Norma Beauchamp and Ronald Funk , currently independent Directors of MedReleaf , to be appointed to the board of directors of Aurora.

The Arrangement Agreement includes customary provisions including reciprocal non-solicitation provisions, subject to the right of each of MedReleaf and Aurora to accept a superior proposal in certain circumstances, with both Aurora and MedReleaf having a five business day right to match any such superior proposal for the other party. The Arrangement Agreement also provides for reciprocal termination fees of C$80 million if the Transaction is terminated in certain specified circumstances, as well as the payment of a C$15 million expense reimbursement fee if the Transaction is terminated in certain other specified circumstances.

In addition to shareholder approvals, the Transaction is subject to the receipt of certain regulatory court and stock exchange approvals and the satisfaction of other conditions customary in transactions of this nature.

Further information regarding the Transaction will be included in the information circulars that Aurora and MedReleaf will prepare, file, and mail in due course to their respective shareholders in connection with their special meetings to be held to consider the Transaction. The Arrangement Agreement will be filed on the SEDAR profiles of MedReleaf and Aurora on the SEDAR website at www.sedar.com .

None of the securities to be issued pursuant to the Arrangement Agreement have been or will be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and any securities issued in the Arrangement are anticipated to be issued in reliance upon the exemption from such registration requirements provided by Section 3(a)(10) of the U.S. Securities Act and applicable exemptions under state securities laws. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Advisors and Counsel

BMO Capital Markets is acting as the exclusive financial advisor to Aurora. McMillan LLP is acting as legal counsel to Aurora.

Canaccord Genuity is acting as the exclusive financial advisor to the special committee of the board of directors of MedReleaf , who also received an independent fairness opinion from GMP Securities , and an independent financial diligence report from Deloitte LLP . Stikeman Elliott LLP is acting as legal counsel to MedReleaf . Davies Ward Phillips & Vineberg LLP is acting as legal counsel to shareholders of MedReleaf .

Press Conference and Analyst Call

Aurora and MedReleaf will hold a press conference at 10:00 a.m. Eastern time , details of which have been disseminated via media advisory. The presentation and multi-media assets will be available at: https://investor.auroramj.com/#/investor-info#aurora-medreleaf

Conference Call and Webcast Access Information

Aurora and MedReleaf will host a webcast conference call, including a slide presentation, to discuss the transaction on Monday, May 14, 2018 , at 11:30 a.m. Eastern time .

Participants may join the conference call by dialing (888) 231-8191 or (647) 427-7450.

A live webcast of the conference call, including the slide presentation, will be available at https://bit.ly/2wB9U4z . Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software downloads that may be required to join the webcast. To view the webcast presentation with slides, please choose either the Real Streaming Audio or Windows Streaming Audio option.

About Aurora

Aurora’s wholly-owned subsidiary, Aurora Enterprises Inc. , is a licensed producer of medical cannabis pursuant to Health Canada ‘s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta , known as “Aurora Mountain”, and a second 40,000 square foot high-technology production facility known as “Aurora Vie” in Pointe-Claire, Quebec on Montreal ‘s West Island . In January 2018 , Aurora’s 800,000 square foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport , was licensed. Once at full capacity, Aurora Sky is expected to produce over 100,000 kg per annum of cannabis. Aurora is completing a facility in Lachute, Quebec utilizing its wholly owned subsidiary Aurora Larssen Projects Inc.

The Company’s wholly-owned subsidiary CanniMed Therapeutics Inc. (“CanniMed”) is Canada ‘s most experienced licensed producer of medical cannabis, with over 20,000 kg per annum in funded capacity. CanniMed forms the heart of Aurora’s Medical Cannabis Centre of Excellence, aimed at product and market development.

Aurora also owns Berlin -based Pedanios GmbH , the leading wholesale importer, exporter, and distributor of medical cannabis in the European Union . The Company owns 51% of Aurora Nordic, which will be constructing a 1,000,000 square foot hybrid greenhouse in Odense, Denmark . The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc. , industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens.

Aurora holds a 25% ownership interest in Alcanna Inc. (formerly Liquor Stores N.A .), (TSX:CLIQ) who are developing a cannabis retail network in Western Canada . In addition, the Company holds approximately 17.23% of the issued shares in extraction technology company Radient Technologies Inc , and has a strategic investment in Hempco Food and Fiber Inc. , with options to increase ownership stake to over 50%. Aurora is also the cornerstone investor in two other licensed producers, with a 22.9% stake in Cann Group Limited , the first Australian company licensed to conduct research on and cultivate medical cannabis, and a 17.62% stake in Canadian producer The Green Organic Dutchman Ltd. , with options to increase to majority ownership.

Aurora’s Common Shares trade on the TSX under the symbol “ACB”, and are a constituent of the S&P /TSX Composite Index

About MedReleaf

Voted Top Licensed Producer at the 2017 Lift Canadian Cannabis Awards, MedReleaf is an R&D-driven company dedicated to innovation, operational excellence and the production of top-quality cannabis. Sourced from around the world and carefully cultivated in one of two state of the art ICH-GMP and ISO 9001 certified facilities in Ontario, the Company delivers a variety of premium products for the global medical market and is committed to serving the therapeutic needs of its medical patients and providing a compelling product assortment for the adult-use recreational consumer. For more information on MedReleaf, its products, research and how the company is helping patients #livefree, please visit MedReleaf.com or follow @medreleaf.

Forward looking statements

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to accretive earnings, anticipated benefits associated with the acquisition of MedReleaf , statements with respect to the effect of the Transaction on the combined company and its strategy going forward, the completion of any capital project or expansions, the timing for the completion of the Transaction; the consideration to be received by shareholders of MedReleaf , which may fluctuate in value due to Aurora common shares forming the consideration; the satisfaction of closing conditions including, without limitation (i) required Aurora and MedReleaf shareholder approvals; (ii) necessary court approval in connection with the plan of arrangement, (iii) receipt of any required approvals under the Competition Act; (iv) certain termination rights available to the parties under the Arrangement Agreement; (v) Aurora obtaining the necessary approvals from the TSX for the listing of its common shares in connection with the Transaction; and (vi) other closing conditions, including, without limitation, compliance by Aurora and MedReleaf with various covenants contained in the Arrangement Agreement. In particular, there can be no assurance that the Transaction will be completed. Forward looking statements are based on certain assumptions regarding Aurora and MedReleaf , including expected growth, results of operations, performance, industry trends and growth opportunities. While Aurora and MedReleaf consider these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability of Aurora to implement its business strategies; competition; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. Aurora and MedReleaf disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in Aurora’s MedReleaf ‘s public filings and the material change reports that will be filed in respect of this Transaction, which are, or will be, available on SEDAR.

Notice to U.S. Holders. Both Aurora and MedReleaf have been formed outside of the United States . Transaction will be subject to disclosure requirements of Canada that are different from those of the United States . Financial statements included in the documents, if any, will be prepared in accordance with Canadian accounting standards and may not be comparable to the financial statements of United States companies. It may be difficult for a securityholder in the United States to enforce his/her/its rights and any claim a securityholder may have arising under the U.S. federal securities laws, since the companies are located in Canada , and some or all of their officers or directors may be residents of Canada or another country outside of the United States . A securityholder may not be able to sue a Canadian company or its officers or directors in a court in Canada or elsewhere outside of the United States for violations of U.S. securities laws. It may be difficult to compel a Canadian company and its affiliates to subject themselves to a U.S. court’s judgment.

AURORA CANNABIS INC.

MEDRELEAF CORP.

Terry Booth

Neil Closner

CEO

CEO

Cision View original content: http://www.prnewswire.com/news-releases/aurora-cannabis-to-acquire-medreleaf-300647512.html

SOURCE Aurora Cannabis Inc.

Tags: , , ,

Important Links

Sponsored Message

View Rate Card